ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 7.00
+0.30 (4.48%)
At close: Jan 22, 2026
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 33.68 million as of January 22, 2026. Its market cap has increased by 127.84% in one year.
Market Cap
33.68M
Enterprise Value
33.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
7.00
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 33.68M, a decrease of -6.73%. That is a compound annual growth rate of -0.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 35.19M | 12.90% |
| Dec 31, 2025 | 31.17M | 521.13% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioventix | 92.74M |
| 4basebio | 91.32M |
| SkinBioTherapeutics | 48.52M |
| Hemogenyx Pharmaceuticals | 41.56M |
| hVIVO | 37.76M |
| Ondine Biomedical | 35.54M |
| Poolbeg Pharma | 34.16M |
| Arecor Therapeutics | 31.15M |